Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Lyka Labs Ltd (LYKALABS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013610
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lyka Labs Ltd (Lyka Labs) is a developer and manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company offers development of various formulations which include lyophilized injections, differentiated dermatological formulation, dry powder injections, and others. It also offers manufacturing services to wide range of pharmaceutical companies. Lyka Labs offers formulation development programs such as product and process optimization, analytical method development, analytical method validation, evaluation and techno-marketing studies, and technology transfer programs. The company markets its products in Romania, Sudan, Ukraine, Venezuela, Vietnam, Combodia, Costa Rica and others. It operates manufacturing facilities in Ankleshwar and Tarapur. Lyka Labs is headquartered in Mumbai, Maharashtra, India.

Lyka Labs Ltd (LYKALABS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lyka Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Lyka Labs Enters Into Technology Transfer Agreement With A Turkish-Based Pharma Company 11
Licensing Agreements 12
Lyka Labs Enters into Licensing Agreement for 12 Sterlite Injectable Formulations 12
Equity Offering 13
Lyka Labs Raises USD5.2 Million in Rights Offering of Shares 13
Asset Transactions 14
Alivira Animal Health to Acquire Veterinary Business from Lyka Labs 14
Lyka Labs Sells Manufacturing Unit for USD6.3 Million 15
Lyka Labs Ltd – Key Competitors 16
Lyka Labs Ltd – Key Employees 17
Lyka Labs Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Strategy And Business Planning 19
Apr 11, 2016: Lyka Labs: Launch of New Marketing Divisions 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Lyka Labs Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Lyka Labs Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Lyka Labs Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Lyka Labs Enters Into Technology Transfer Agreement With A Turkish-Based Pharma Company 11
Lyka Labs Enters into Licensing Agreement for 12 Sterlite Injectable Formulations 12
Lyka Labs Raises USD5.2 Million in Rights Offering of Shares 13
Alivira Animal Health to Acquire Veterinary Business from Lyka Labs 14
Lyka Labs Sells Manufacturing Unit for USD6.3 Million 15
Lyka Labs Ltd, Key Competitors 16
Lyka Labs Ltd, Key Employees 17
Lyka Labs Ltd, Other Locations 18
Lyka Labs Ltd, Subsidiaries 18

★海外企業調査レポート[Lyka Labs Ltd (LYKALABS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orlando Utilities Commission:発電所・企業SWOT分析
    Orlando Utilities Commission - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Bucher Industries AG:企業の戦略・SWOT・財務情報
    Bucher Industries AG - Strategy, SWOT and Corporate Finance Report Summary Bucher Industries AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • University of Tennessee Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary University of Tennessee Research Foundation (UTRF) is a non profit organization that promotes commercialization of UT intellectual property and encourages an entrepreneurial culture and contributes to state and regional economic development, and promotes research and education. The organizat …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • Gunvor Group Ltd:企業の戦略的SWOT分析
    Gunvor Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Publix Super Markets Inc:企業の戦略的SWOT分析
    Publix Super Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Gridsum Holding, Inc. (GSUM):企業の財務・戦略的SWOT分析
    Gridsum Holding, Inc. (GSUM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sun Resources NL (SUR):企業の財務・戦略的SWOT分析
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • Etrion Corp (ETX):企業の財務・戦略的SWOT分析
    Summary Etrion Corp (Etrion) formerly PetroFalcon Corp, is a solar energy development company. The company produce power and builds, owns and operates utility-scale solar power generation plants. It develops greenfield solar power projects in Japan and Chile. Etrion owns and operates 56.7 MW of sola …
  • hVIVO Plc (HVO):企業の財務・戦略的SWOT分析
    Summary hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human di …
  • Just Group plc:企業の戦略・SWOT・財務情報
    Just Group plc - Strategy, SWOT and Corporate Finance Report Summary Just Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • AbSci LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary AbSci LLC (AbSci) is a biotechnology company which develops protein production technologies. The company offers SoluPro, a genetically engineered semi-oxidizing cytoplasm and a dual inducible promoter system that enables scalable production of antibodies, antibody fragments, and other solubl …
  • Genoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genoptix Inc (Genoptix) is a hematopathology center which provides oncology diagnostics and informatics services specializing in hematology and solid tumors. The center offers biopharma and healthcare laboratory, discovery, drug development, care and cost development, and patient services. G …
  • Bengal Energy Ltd (BNG):石油・ガス:M&Aディール及び事業提携情報
    Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets in Australia’s Cooper Basin and India’s Cauvery Basin. The company holds interest in Toooko …
  • Albireo Pharma Inc (ALBO):製薬・医療:M&Aディール及び事業提携情報
    Summary Albireo Pharma Inc (Albireo), formerly Biodel Inc., focuses on the development and commercialization of innovative bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal (GI) disorders and diseases where inappropriate flow of bile causes severe med …
  • Ortho-Clinical Diagnostics Inc:企業のM&A・事業提携・投資動向
    Ortho-Clinical Diagnostics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ortho-Clinical Diagnostics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Shermco Industries, Inc.-エネルギー分野:企業M&A・提携分析
    Summary Shermco Industries, Inc. (Shermco), a member of the GFI Energy Group of Oaktree Capital Management LP, is an independent service company that provides electrical maintenance, repair, testing, and analysis services for electrical systems and equipment. It also offers industrial contracting, u …
  • Atradius NV:企業の戦略的SWOT分析
    Atradius NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Paratek Pharmaceuticals Inc (PRTK):企業の財務・戦略的SWOT分析
    Paratek Pharmaceuticals Inc (PRTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆